Candel Therapeutics
CADL
CADL
20 hedge funds and large institutions have $5.97M invested in Candel Therapeutics in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
9% less funds holding
Funds holding: 22 → 20 (-2)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
Holders
20
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$183K | |
| 2 | +$60.5K | |
| 3 | +$52.9K | |
| 4 |
TIA
Traphagen Investment Advisors
Oradell,
New Jersey
|
+$27.2K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$22K |
Top Sellers
| 1 | -$439K | |
| 2 | -$79K | |
| 3 | -$24.8K | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$24.3K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$19.1K |